Walleye Capital
EIKN icon

Walleye Capital’s Eikon Therapeutics EIKN Stock Holding History

Walleye Capital’s Portfolio EIKN Stock Details EIKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.15M Buy
+391,273
New +$3.94M ﹤0.01% 2375

Other funds holding EIKN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Merck & Co
Merck & Co Rahway, New Jersey $820M AUM 395.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Regents of the University of California
Regents of the University of California Oakland, California $6.64B AUM 23.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
SCM
Soros Capital Management New York $182M AUM 108.83% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return

Walleye Capital's EIKN Position: Q3 2026 in Review

Walleye Capital opened a new position in Eikon Therapeutics (EIKN) in Q3 2026: 391,273 shares worth $3.15M. The stake represents ﹤0.01% of the portfolio and ranks #2375 among its holdings.

63 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.

  • Walleye Capital held 391,273 shares of Eikon Therapeutics worth $3.15M as of Q3 2026.
  • Eikon Therapeutics was a new Walleye Capital position in Q3 2026.
  • Eikon Therapeutics made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2375 holding.
  • 63 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.